A Bio-Orthogonal Engineered Chitosan Platform for Enhanced Mesenchymal Stem Cells Delivery and Function in Peripheral...

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Neuroscience

Background:

• Mesenchymal stem cell (MSC) therapy shows promise for peripheral nerve repair.
• Current MSC therapies face challenges with low cell viability and retention at implantation sites.
• Chitosan scaffolds are explored for nerve regeneration applications.

Purpose of the Study:

• To develop a bio-orthogonal strategy for covalently integrating MSCs with chitosan scaffolds.
• To enhance MSC survival, retention, and therapeutic efficacy for peripheral nerve regeneration.
• To investigate the mechanisms underlying improved nerve repair using this novel strategy.

Main Methods:

• Covalent integration of MSCs with chitosan scaffolds using a bio-orthogonal strategy.
• In vitro assessment of MSC adhesion, survival, and signaling pathways (PI3K/Akt).
• Quantitative proteomics to analyze secreted neurotrophic factors.
• In vivo studies using nerve crush and sciatic nerve transection models to evaluate cell retention, immune modulation, angiogenesis, and nerve repair.

Main Results:

• Covalent linkage enhanced MSC adhesion and survival on chitosan scaffolds via PI3K/Akt signaling.
• Proteomics confirmed increased secretion of neurotrophic factors essential for nerve regeneration.
• In vivo studies demonstrated improved MSC retention, modulated immune response, accelerated Wallerian degeneration, enhanced angiogenesis, and ECM remodeling.
• Significant improvement in therapeutic efficacy was observed in sciatic nerve transection models.

Conclusions:

• The bio-orthogonal strategy provides a simple, efficient, and translatable method to enhance MSC-mediated peripheral nerve repair.
• This approach improves cell viability and retention, crucial for successful nerve regeneration.
• The study establishes a foundation for clinical applications of chitosan-MSC composites in neuroregenerative medicine.